Dr. Zhixun Dou, Ph.D., is a principal investigator affiliated with Harvard Medical School and Massachusetts General Hospital, and is a core faculty member at the Harvard Stem Cell Institute. His lab focuses on understanding nuclear-level mechanisms driving aging and cancer, particularly how chromatin dynamics and nuclear events influence cellular function. Dr. Dou’s team has made groundbreaking discoveries in the molecular regulation of inflammation and cell therapy, and the lab’s work continues to shed light on key pathways involved in tissue regeneration, chronic disease, and therapeutic interventions.